Aptose Biosciences INC. (APTOF) — DEF 14A Filings
All DEF 14A filings from Aptose Biosciences INC.. Browse 4 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (4)
-
Aptose Biosciences DEF 14A: Executive Comp & Equity Awards
— Apr 28, 2025 Risk: medium
Aptose Biosciences Inc. filed a DEF 14A on April 28, 2025, for the period ending May 27, 2025. The filing details executive compensation and equity awards for t -
Aptose Biosciences Inc. Files Definitive Proxy Statement
— Dec 30, 2024 Risk: low
Aptose Biosciences Inc. filed a Definitive Proxy Statement (DEF 14A) on December 30, 2024, for its annual meeting on January 27, 2025. The filing details the co -
Aptose Biosciences Files Definitive Proxy Statement
— Jul 17, 2024 Risk: low
Aptose Biosciences Inc. filed a definitive proxy statement (DEF 14A) on July 17, 2024, for its annual meeting of stockholders scheduled for August 15, 2024. The -
Aptose Biosciences Inc. files Definitive Proxy Statement for June 18, 2024 Annual Meeting
— May 15, 2024 Risk:
Aptose Biosciences Inc. (APTOF) filed a Proxy Statement (DEF 14A) with the SEC on May 15, 2024. Aptose Biosciences Inc. filed a Definitive Proxy Statement (DEF
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX